Group News

June 2009
Biraja Kanungo received his Ph.D. in Materials Science for his thesis "Mechanical Properties of Collagen-Based Scaffolds for Tissue Regeneration"..

May 2009
Research on the bi-layer osteochondral scaffold is in the MIT TechTalk
as well as in the Forbes magazine.

January 2009
Orthomimetics Limited has received CE Mark approval for Chondromimetic, its flagship product for the repair of articular cartilage and bone.  Chondromimetic is a novel off-the-shelf implant that helps to support the repair of defects involving both articular cartilage and bone - defects that can result from sports injuries, surgical intervention and other trauma.  CE-mark approval enables the company to market Chondromimetic in Europe.

Orthomimetics' press release can be viewed here.

December 2008 Dr Andrew Lynn, Founder and CEO of Orthomimetics Ltd, has been selected from a host of entrants to receive the top European Award for University Entrepreneurs in Chemistry and Materials in the inaugural Academic Enterprise Awards 2008. The award is in recognition of his achievements as founder of a successful spin-out from a collaboration between the University of Cambridge and our group at the Massachusetts Institute of Technology.

Fall 2008 Orthomimetics, a spin-off company from our collaborative research with Prof. Bill Bonfield's group at Cambridge University, has applied for approval to use the osteochondral scaffolds jointly developed at MIT and Cambridge in human clinical trials in Europe.

June 2008 Professor Lorna Gibson stepped down as Associate Provost.  Professor Gibson is on sabbatical for the 2008-2009 academic year.

June 2008
Matt Dawson received his PhD in June 2008 for his thesis "Modelling the Dynamic Response of Low-Density, Reticulated Elastomeric Foam Impregnated with Newtonian and non-Newtonian Fluids”.  Matt is currently working at Exxon Mobil in Houston TX.